Bausch + Lomb Acquires Trukera Medical to Strengthen Dry Eye Diagnostics and Preoperative Care

Aug 21, 2024 10:01 CST Updated 10:01

Trukera Medical

Comprehensive Corneal Health Technology Developer

Source: Eye Future; Editor: Sophia

Reprint Requirements: Can be reprinted 24 hours after the first publication, source must be credited.

Recently,Bausch + Lomb (Bausch + Lomb）Announced that its subsidiary has been acquired from private equity owner AccelMed Partners and other shareholders.Acquired Trukera Medical。This acquisitionWill help to expand Bausch + Lomb's surgical business in the United States,Enhance its product portfolio in the field of dry eye treatment,Strengthen its leading position in the dry eye syndrome field。

Trukera Medical is a U.S.-basedOphthalmology Medical Diagnosis Company, the developed ScoutPro® isThe Only One in the WorldPortable Tear Osmolarity Testing Device, used for precise measurement of tear osmolarity.Hypertonicity (high osmolarity) is a condition that cannot be detected by slit-lamp examination., is a key indicator and core cause of asymptomatic dry eye disease (DED) and ocular surface disease (OSD). If not effectively treated before surgery, it may negatively impact the outcomes of corneal, cataract, and refractive surgeries.

President of Bausch + Lomb Surgical Luc Bonnefoy Emphasized the strategic importance of integrating ScoutPro into its products: "As a global leader in dry eye management as well as cataract and refractive medical devices and implants,We have unique advantages in optimizing preoperative preparation., which helps to ensure good results after surgery.ScoutPro®Has become a preoperative diagnostic tool for many American surgeons,ByGiven our scale, we believe it can play a bigger role.”

TrukCEO and President of Trukera MedicalAdam Szaronos Said: "Due to the negative impact of high osmotic pressure on visual quality and patient satisfaction after cataract surgery, we have developed relevant diagnostic tools to meet the needs of both patients and doctors."I am very glad to be able to extend this valuable tool to more doctors, benefiting more patients."

# ScoutPro®

Research and Development Background

The prevalence of tear hyperosmolarity is very high.More than 63% of patients experience moderate or higher levels of tear hyperosmolarity after ophthalmic surgery.(Osmotic pressure ≥ 308mOsm). High tear osmolarity can cause scattering, with a level of scattering equivalent to that of grade II or III cataracts. This can lead to a more than sevenfold decrease in patient satisfaction post-surgery.

The guidelines of the American Society of Cataract and Refractive Surgery (ASCRS) committee considerOsmolarity measurement is essential for the diagnosis and management of Visually Significant OSD (Ocular Surface Disease).. But due to the bulky and large equipment of traditional detection methods, the penetration rate is only about 3%.

ScoutPro developed by Trukera Medical isThe Only One in the WorldPortable tear osmolarity testing device,It uses advanced microfluidic impedance spectroscopy for real-time measurement, completing the collection and analysis of nanoliter tear samples in a single device.Integrated tear collection and osmolarity testing，Accurate measurement of osmotic pressure can be achieved in about 15 seconds.。

ScoutPro is designed to quantitatively measure the osmolarity of human tear fluid and is used in conjunction with other clinical assessment methods.Can Help Diagnose Dry Eye Syndrome, applicable to patients suspected of having dry eye syndrome.

Product Advantages

Portable:Integrated sample collection and analysis;

Practical:Simplify the end-to-end detection process;

Precision:In 24 million tests, with a trusted labThe accuracy is the same.

ScoutPro Utilizes Temperature-CorrectedImpedance measurement to indirectly assess osmotic pressureBy applying a calibration curve to the steady-state impedance of tears, the osmolarity is calculated and displayed as a quantitative value.

Its system components include:ScoutPro Pen: A portable device used to connect test cards and collect tear samples, capable of rapidly collecting 50 nanoliters (nL) of tears through a microfluidic channel;Charging Dock: Charge the ScoutPro pen;Osmotic Pressure Test Card: For single use, used to collect tears and measure their osmolarity;Electronic Inspection Card: Used to verify the functionality and calibration of ScoutPro.

# About Trukera Medical

Trukera Medical, formerly known as TearLab, was founded in 2009 based on the recognition of the importance of corneal health in eye care practice.

In 2022, the company was renamed Trukera Medical.，Business expansion into the corneal care field. The company initiallyFocus on Osmolality Testing, is now a comprehensive corneal care company dedicated to addressing other unmet needs in the field of eye health.

# Global Leading Ophthalmic Device and Consumables Company

# Chinese Ophthalmic Devices and Consumables Companies

# Chinese Ophthalmology Medical Service Company

# Overseas Ophthalmology Startups